Register

Login

Vet Times logo
+
  • View all news
  • Vets news
  • Vet Nursing news
  • Business news
  • + More
    • Videos
    • Podcasts
    • Crossword
  • View all clinical
  • Small animal
  • Livestock
  • Equine
  • Exotics
  • All Jobs
  • Your ideal job
  • Post a job
  • Career Advice
  • Students
About
Contact Us
For Advertisers
NewsClinicalJobs
Vet Times logo

Vets

All Vets newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Vet Nursing

All Vet Nursing newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Business

All Business newsHuman resourcesBig 6SustainabilityFinanceDigitalPractice profilesPractice developments

+ More

VideosPodcastsDigital EditionCrossword

The latest veterinary news, delivered straight to your inbox.

Choose which topics you want to hear about and how often.

Vet Times logo 2

About

The team

Advertise with us

Recruitment

Contact us

Vet Times logo 2

Vets

All Vets news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Vet Nursing

All Vet Nursing news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Business

All Business news

Human resources

Big 6

Sustainability

Finance

Digital

Practice profiles

Practice developments

Clinical

All Clinical content

Small animal

Livestock

Equine

Exotics

Jobs

All Jobs content

All Jobs

Your ideal job

Post a job

Career Advice

Students

More

All More content

Videos

Podcasts

Digital Edition

Crossword


Terms and conditions

Complaints policy

Cookie policy

Privacy policy

fb-iconinsta-iconlinkedin-icontwitter-iconyoutube-icon

© Veterinary Business Development Ltd 2025

IPSO_regulated

29 Apr 2022

Vet help sought for FIP treatments study

Novel treatments GS-441524 and remdesivir are legally available to vets in the UK and Australia to use for the disease, and a study wants to find out how cats have responded.

author_img

Paul Imrie

Job Title



Vet help sought for FIP treatments study

Specialist feline vets are seeking help for a study into how cats have responded to FIP treatments GS-441524 and remdesivir.

The novel treatments, originally available in Australia and then in the UK since 2021, are available for vets to prescribe, although not yet in all countries.

Specialists in both countries now want to compile as much robust evidence as they can on the efficacy and possible side effects of the treatment, in the hope all information will allow the drugs to be legally imported into more countries to treat cats with FIP.

Robust evidence

The International Society of Feline Medicine, the University of Surrey and The University of Sydney are involved in the study, with the UK FIP advice team involving leading vets Sam Taylor, Emi Barker, Séverine Tasker, Stephanie Sorrell and Danièlle Gunn-Moore.

In a letter calling for assistance from vets, the FIP advice team said: “Unfortunately, vets in many countries do not have access to these drugs as importation rules require robust evidence for their efficacy and any possible side effects. We would, therefore, like to record how cats around the world treated with legal drugs have responded (successfully or not) to the treatments and whether any adverse effects occurred.

“By telling us about the case(s) you treated, whatever the outcome, we can learn more about the efficacy of these drugs to inform FIP treatment globally.”

Case histories

Participants can complete a spreadsheet for their cases or, if they prefer, case histories and results with the client details removed, or with express owner permission. These can be sent to [email protected] in the UK and Europe, and [email protected] in Australia.

The FIP advice team added: “These results will immediately have any owner details removed to maintain data handling rules, but the owner’s permission must be sought to send the data.

“Sharing a cat’s data is permissible and not subject to GDPR rules (UK), so please do anonymise the data yourself if you prefer, removing the client’s name and address.”

Anyone with further queries can email [email protected]